Haha yes, but it's a blinded trial so no-one (including the physician) should know if the patient got the active or not. Makes sense or is investing in biotech purely a blind punt for you?
Ann: Phase 2 Synovial Fluid Biomarker Study Update, page-52
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.005(2.17%) |
Mkt cap ! $83.95M | |||
| Open | High | Low | Value | Volume |
| 23.0¢ | 25.0¢ | 23.0¢ | $138.4K | 588.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 26061 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 27172 | 7 |
View Market Depth
| Last trade - 14.46pm 06/08/2024 (20 minute delay) ? |
| PAR (ASX) Chart |